Omnicell Debt to Equity Ratio 2010-2025 | OMCL

Current and historical debt to equity ratio values for Omnicell (OMCL) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Omnicell debt/equity for the three months ending March 31, 2025 was 0.13.
Omnicell Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2025-03-31 $0.89B $1.26B 0.71
2024-12-31 $0.88B $1.24B 0.71
2024-09-30 $1.07B $1.23B 0.87
2024-06-30 $1.09B $1.20B 0.91
2024-03-31 $1.10B $1.19B 0.92
2023-12-31 $1.04B $1.19B 0.87
2023-09-30 $1.03B $1.19B 0.87
2023-06-30 $1.03B $1.16B 0.89
2023-03-31 $1.11B $1.14B 0.97
2022-12-31 $1.08B $1.13B 0.96
2022-09-30 $1.04B $1.14B 0.92
2022-06-30 $1.04B $1.09B 0.95
2022-03-31 $1.05B $1.08B 0.98
2021-12-31 $1.00B $1.15B 0.87
2021-09-30 $0.94B $1.11B 0.85
2021-06-30 $0.91B $1.05B 0.86
2021-03-31 $0.88B $1.01B 0.87
2020-12-31 $0.86B $0.97B 0.89
2020-09-30 $0.80B $0.92B 0.87
2020-06-30 $0.34B $0.89B 0.38
2020-03-31 $0.35B $0.88B 0.40
2019-12-31 $0.40B $0.85B 0.47
2019-09-30 $0.44B $0.81B 0.54
2019-06-30 $0.42B $0.77B 0.55
2019-03-31 $0.45B $0.73B 0.61
2018-12-31 $0.40B $0.68B 0.59
2018-09-30 $0.43B $0.62B 0.70
2018-06-30 $0.44B $0.59B 0.74
2018-03-31 $0.47B $0.58B 0.81
2017-12-31 $0.46B $0.55B 0.83
2017-09-30 $0.45B $0.47B 0.96
2017-06-30 $0.46B $0.45B 1.02
2017-03-31 $0.47B $0.44B 1.07
2016-12-31 $0.50B $0.43B 1.17
2016-09-30 $0.50B $0.43B 1.18
2016-06-30 $0.50B $0.41B 1.21
2016-03-31 $0.51B $0.41B 1.25
2015-12-31 $0.18B $0.40B 0.44
2015-09-30 $0.19B $0.39B 0.47
2015-06-30 $0.20B $0.40B 0.51
2015-03-31 $0.17B $0.41B 0.41
2014-12-31 $0.17B $0.39B 0.44
2014-09-30 $0.17B $0.38B 0.44
2014-06-30 $0.16B $0.38B 0.42
2014-03-31 $0.15B $0.37B 0.40
2013-12-31 $0.14B $0.35B 0.41
2013-09-30 $0.15B $0.36B 0.41
2013-06-30 $0.14B $0.33B 0.42
2013-03-31 $0.14B $0.32B 0.42
2012-12-31 $0.13B $0.31B 0.44
2012-09-30 $0.13B $0.30B 0.42
2012-06-30 $0.12B $0.29B 0.41
2012-03-31 $0.08B $0.29B 0.29
2011-12-31 $0.08B $0.28B 0.29
2011-09-30 $0.08B $0.28B 0.29
2011-06-30 $0.08B $0.27B 0.29
2011-03-31 $0.08B $0.27B 0.29
2010-12-31 $0.08B $0.27B 0.29
2010-09-30 $0.08B $0.26B 0.30
2010-06-30 $0.08B $0.26B 0.30
2010-03-31 $0.08B $0.25B 0.32
2009-12-31 $0.08B $0.24B 0.33
2009-09-30 $0.08B $0.24B 0.32
2009-06-30 $0.08B $0.24B 0.32
2009-03-31 $0.07B $0.24B 0.30
Sector Industry Market Cap Revenue
Medical Medical Information Systems $1.322B $1.112B
Omnicell Inc., develops and markets end-to-end automation solutions for the medication-use process. These automation solutions contain medication and supply dispensing systems, central pharmacy storage, retrieval and packaging solutions, a bedside automation solution, a physician order management solution, a decision support application, and a Web-based procurement application. The products offered by the company enable care providers to improve patient safety and increase efficiency by lowering costs. The company also adheres to regulatory compliances and addresses issues related to population health.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $37.908B 52.36
Hims & Hers Health (HIMS) United States $12.273B 127.51
Tempus AI (TEM) United States $10.774B 0.00
IRhythm Technologies (IRTC) United States $4.555B 0.00
Inspire Medical Systems (INSP) United States $4.224B 66.00
Privia Health (PRVA) United States $2.787B 190.50
Enovis (ENOV) United States $1.803B 10.05
Clover Health Investments (CLOV) United States $1.623B 0.00
Schrodinger (SDGR) United States $1.563B 0.00
Phreesia (PHR) United States $1.431B 0.00
Azenta (AZTA) United States $1.236B 57.45
10x Genomics (TXG) United States $1.006B 0.00
Fulgent Genetics (FLGT) United States $0.618B 0.00
Butterfly Network (BFLY) United States $0.537B 0.00
Veradigm (MDRX) United States $0.476B 0.00
Talkspace (TALK) United States $0.472B 141.00
Claritev (CTEV) United States $0.437B 0.00
TruBridge (TBRG) United States $0.357B 791.00
Standard BioTools (LAB) United States $0.350B 0.00
Outset Medical (OM) United States $0.318B 0.00
Nyxoah SA (NYXH) Belgium $0.264B 0.00
Health Catalyst (HCAT) United States $0.254B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.190B 0.00
EUDA Health Holdings (EUDA) Singapore $0.140B 0.00
Pulmonx (LUNG) United States $0.125B 0.00
American Well (AMWL) United States $0.116B 0.00
MDxHealth SA (MDXH) Belgium $0.096B 0.00
CareCloud (CCLD) United States $0.084B 3.21
111 (YI) China $0.069B 0.00
HeartBeam (BEAT) United States $0.056B 0.00
P3 Health Partners (PIII) United States $0.052B 0.00
Zepp Health (ZEPP) Netherlands $0.037B 0.00
Zhongchao (ZCMD) China $0.029B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.026B 0.00
Bullfrog AI Holdings (BFRG) United States $0.017B 0.00
Precipio (PRPO) United States $0.015B 0.00
MSP Recovery (MSPR) United States $0.012B 0.00
Strata Skin Sciences (SSKN) United States $0.011B 0.00
Streamline Health Solutions (STRM) United States $0.009B 0.00
Predictive Oncology (POAI) United States $0.009B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Movano (MOVE) United States $0.004B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
Healthcare Triangle (HCTI) United States $0.000B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00